Welcome to our dedicated page for Addus HomeCare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Addus HomeCare Corporation filings document a home care provider with personal care, hospice and home health operations. Form 8-K reports furnish quarterly and annual results of operations, Regulation FD disclosures and exhibit press releases, while amended 8-K filings provide acquisition-related financial statements and pro forma information for the completed purchase of Gentiva's personal care business by Addus HealthCare, a wholly owned subsidiary.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation votes and related governance disclosures. The filing record also includes capital-structure, material-event and shareholder-vote disclosures for the company's common stock.
On June 18, 2025, Addus HomeCare Corp. (ADUS) filed a Form 4 reporting that board director Michael Earley was granted 1,172 restricted common shares at a purchase price of $0. The award will vest in full on June 18, 2026. After the grant, Earley now directly owns 11,951 ADUS shares and indirectly controls 2,695 shares through Bird Asset Management, LP, bringing his total beneficial ownership to 14,646 shares. No derivative securities were involved, and the filing does not reference any Rule 10b5-1 trading plan. Because the shares were awarded rather than purchased, the disclosure primarily reflects routine equity compensation intended to align the director’s interests with shareholders and encourage board retention, carrying limited immediate market impact.